Novartis Venture Fund
Alejandro Penagos is a seasoned professional in the pharmaceutical industry with extensive experience spanning over 20 years. Currently serving as TA Head In-Market Brands & Strategic Alliances for Canada & Latin America at Novartis since January 2018, Alejandro has driven strategy, performance, and execution in innovative market portfolios and strategic partnerships. Previous roles at Novartis include Executive Director for Innovative Access & Policy and interim Therapeutic Area Head. Alejandro's leadership extends to FIFARMA, where responsibilities include co-chairing the Strategic Alliances Working Group and the Value, Access & Innovation Working Group, advocating for timely access to innovative medicines across Latin America. Alejandro's background also encompasses significant positions at Novo Nordisk and Boehringer Ingelheim, along with a strong educational foundation in Pharmaceutical Chemistry and an MBA.
This person is not in any teams
This person is not in any offices
Novartis Venture Fund
3 followers
Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. In their investments, they look for unmet need and clinical impact, novel proprietary science, and understanding of the mechanism, management, and board experience and capital efficiency in the program.